Results 21 to 30 of about 114,465,275 (302)

Implementation, availability and regulatory status of an OECD accepted Reconstructed Human Epidermis model in Brazil

open access: yesVigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia, 2018
Introduction: In 2014, Brazil has joined the growing list of countries to ban cosmetic products from being tested on animal models. The new legislation comes into force in 2019.
Rodrigo De Vecchi   +8 more
doaj   +7 more sources

Roles for In Vitro Myelotoxicity Tests in Preclinical Drug Development and Clinical Trial Planning [PDF]

open access: yesToxicologic Pathology, 1993
Myelosuppression is the dose-limiting side effect for most anti-cancer and many anti-human immunodeficiency virus agents, which can be quantitated with optimized colony-forming assays (granulocyte-macrophage, late erythroid, and megakaryocytic [for murine only] colony-forming units and early erythroid burst-forming units (BFUs)).
R E, Parchment   +2 more
openaire   +2 more sources

Gas transport during in vitro and in vivo preclinical testing of inert gas therapies [PDF]

open access: yesMedical Gas Research, 2016
New gas therapies using inert gases such as xenon and argon are being studied, which require in vitro and in vivo preclinical experiments. Examples of the kinetics of gas transport during such experiments are analyzed in this paper. Using analytical and numerical models, we analyze an in vitro experiment for gas transport to a 96 cell well plate and an
Katz, Ira   +5 more
openaire   +2 more sources

Preclinical Safety Assessment: In vitro – in vivo Testing [PDF]

open access: yesPharmacology & Toxicology, 2000
Abstract: In vitro– and in vivo preclinical safety tests on drug candidates needed before first dose in man and before marketing authorisation are as follows: The acute and repeated dose toxicity studies, the reproductive toxicity studies, the genotoxicity studies, the carcinogenicity studies and finally the safety pharmacology studies.
openaire   +2 more sources

Organ-on-a-chip microengineering for bio-mimicking disease models and revolutionizing drug discovery

open access: yesBiosensors and Bioelectronics: X, 2022
The core of the drug research and screening processes is predicting the effect of drugs prior to human clinical trials. Due to the 2D cell culture and animal models' poor predictability, the cost of drug discovery is continuously rising.
Tanvir Ahmed
doaj   +1 more source

Isolation and Characterization of Primary DMD Pig Muscle Cells as an In Vitro Model for Preclinical Research on Duchenne Muscular Dystrophy

open access: yesLife, 2022
Duchenne muscular dystrophy (DMD) is the most frequent genetic myopathy in childhood and leads to progressive muscle atrophy, weakness, and premature death. So far, there is no curative treatment available.
Tina Donandt   +6 more
doaj   +1 more source

Characterization of phototoxicity reactions in human and animal skin models [PDF]

open access: yes, 2013
Phototoxicity is a relatively common phenomenon and is an adverse effect of some systemic drugs. A large number of pharmaceutical drug substances are known to carry the potential to elicit a phototoxic response (Moore 2002, Ferguson 2002). Reported cases
Boudon, Stéphanie
core   +1 more source

Reconstruction of destruction – in vitro reconstitution methods in autophagy research [PDF]

open access: yes, 2018
International audienceAutophagy is one of the most elaborative membrane remodeling systems in eukaryotic cells. Its major function is to recycle cytoplasmic material by delivering it to lysosomes for degradation.
Wollert, Thomas, Moparthi, Satish Babu
core   +1 more source

Developing preclinical models of neuroblastoma: driving therapeutic testing

open access: yesBMC Biomedical Engineering, 2019
Despite advances in cancer therapeutics, particularly in the area of immuno-oncology, successful treatment of neuroblastoma (NB) remains a challenge. NB is the most common cancer in infants under 1 year of age, and accounts for approximately 10% of all ...
Kimberly J. Ornell, Jeannine M. Coburn
doaj   +1 more source

Consensus Guidelines for the Design and In Vitro Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides

open access: yesNucleic Acid Therapeutics, 2022
Antisense oligonucleotides (ASOs) can modulate pre-mRNA splicing. This offers therapeutic opportunities for numerous genetic diseases, often in a mutation-specific and sometimes even individual-specific manner. Developing therapeutic ASOs for as few as even a single patient has been shown feasible with the development of Milasen for an individual with ...
Aartsma-Rus, A.   +8 more
openaire   +6 more sources

Home - About - Disclaimer - Privacy